A Phase 1 Dose Escalation Study of ZG006 in Patients With Small Cell Lung Cancer
A Phase 1 Dose Escalation Study of ZG006 in Patients With Small Cell Lung Cancer
Recruiting · NCT06592638 · Registry updated 2025-08-06Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| A Phase 1 Dose Escalation Study of ZG006 in Patients With Small Cell Lung Cancer | Neoplasms by Site, Thoracic Neoplasms, bronchial neoplasm, bronchogenic carcinoma, lung disorder, lung neoplasm, neoplasm, respiratory system disorder, respiratory tract neoplasm, small cell lung carcinoma | Recruiting | Phase 1 | 2025-08-06 | NCT06592638 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Suzhou Zelgen Biopharmaceuticals Co.,Ltd | 23 |
6 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Zelgen Site 101 | Canton | United States | 1 |
| Zelgen Site 102 | Plantation | United States | 1 |
| Zelgen Site 103 | Lexington | United States | 1 |
| Zelgen Site 104 | Cleveland | United States | 1 |
| Zelgen Site 105 | Orange | United States | 1 |
| Zelgen Site 106 | Houston | United States | 1 |